Myanmar

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
2.39 (1.99 - 2.71)	2019	Modelled	IHME
2.45 (2.09 - 2.76)	2018	Modelled	IHME
2.5 (2.14 - 2.85)	2017	Modelled	IHME
2.53 (2.17 - 2.86)	2016	Modelled	IHME
2.56 (2.18 - 2.92)	2015	Modelled	IHME
2.6 (2.22 - 2.98)	2014	Modelled	IHME
2.66 (2.27 - 3.06)	2013	Modelled	IHME
2.73 (2.33 - 3.14)	2012	Modelled	IHME
2.79 (2.36 - 3.24)	2011	Modelled	IHME
2.84 (2.39 - 3.32)	2010	Modelled	IHME
2.89 (2.43 - 3.37)	2009	Modelled	IHME
2.93 (2.44 - 3.39)	2008	Modelled	IHME
2.98 (2.46 - 3.44)	2007	Modelled	IHME
3.01 (2.49 - 3.49)	2006	Modelled	IHME
3.05 (2.52 - 3.54)	2005	Modelled	IHME
3.08 (2.56 - 3.58)	2004	Modelled	IHME
3.12 (2.59 - 3.62)	2003	Modelled	IHME
3.15 (2.63 - 3.63)	2002	Modelled	IHME
3.18 (2.65 - 3.65)	2001	Modelled	IHME
3.21 (2.66 - 3.71)	2000	Modelled	IHME
3.24 (2.71 - 3.74)	1999	Modelled	IHME
3.28 (2.76 - 3.78)	1998	Modelled	IHME
3.31 (2.80 - 3.83)	1997	Modelled	IHME
3.33 (2.82 - 3.86)	1996	Modelled	IHME
3.34 (2.82 - 3.88)	1995	Modelled	IHME
3.34 (2.82 - 3.87)	1994	Modelled	IHME
3.32 (2.79 - 3.84)	1993	Modelled	IHME
3.28 (2.75 - 3.81)	1992	Modelled	IHME
3.24 (2.69 - 3.76)	1991	Modelled	IHME
3.19 (2.63 - 3.71)	1990	Modelled	IHME
8.7	2013	Survey/reported	Zaw S et al, 2013
4.18 (0.28 - 41.28)	2015	Modelled	WHO
8.3 (4.60 - 9.40)	2016	Modelled	Razavi-Shearer et al, 2018

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.61 (0.46 - 0.82)	2019	Modelled	IHME
0.64 (0.48 - 0.88)	2018	Modelled	IHME
0.68 (0.50 - 0.92)	2017	Modelled	IHME
0.73 (0.56 - 0.97)	2016	Modelled	IHME
0.76 (0.58 - 0.99)	2015	Modelled	IHME
0.76 (0.57 - 0.98)	2014	Modelled	IHME
0.74 (0.56 - 0.97)	2013	Modelled	IHME
0.73 (0.54 - 0.96)	2012	Modelled	IHME
0.72 (0.53 - 0.96)	2011	Modelled	IHME
0.71 (0.52 - 0.96)	2010	Modelled	IHME
0.72 (0.53 - 0.96)	2009	Modelled	IHME
0.75 (0.55 - 1)	2008	Modelled	IHME
0.79 (0.58 - 1.04)	2007	Modelled	IHME
0.84 (0.62 - 1.11)	2006	Modelled	IHME
0.9 (0.66 - 1.19)	2005	Modelled	IHME
1.07 (0.79 - 1.40)	2004	Modelled	IHME
1.38 (1.03 - 1.80)	2003	Modelled	IHME
1.73 (1.29 - 2.28)	2002	Modelled	IHME
2.03 (1.53 - 2.68)	2001	Modelled	IHME
2.18 (1.63 - 2.91)	2000	Modelled	IHME
2.23 (1.67 - 2.95)	1999	Modelled	IHME
2.27 (1.67 - 2.97)	1998	Modelled	IHME
2.29 (1.67 - 3.01)	1997	Modelled	IHME
2.31 (1.70 - 3.04)	1996	Modelled	IHME
2.32 (1.71 - 3.07)	1995	Modelled	IHME
2.31 (1.70 - 3.02)	1994	Modelled	IHME
2.29 (1.69 - 2.98)	1993	Modelled	IHME
2.26 (1.66 - 2.93)	1992	Modelled	IHME
2.22 (1.64 - 2.88)	1991	Modelled	IHME
2.17 (1.58 - 2.83)	1990	Modelled	IHME
2.03 (0.13 - 25.84)	2015	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
1,309,700 (1,081,050 - 1,524,440)	1990	Modelled	IHME
1,352,020 (1,122,780 - 1,567,500)	1991	Modelled	IHME
1,389,640 (1,163,060 - 1,611,920)	1992	Modelled	IHME
1,422,120 (1,196,110 - 1,646,160)	1993	Modelled	IHME
1,448,960 (1,224,050 - 1,682,430)	1994	Modelled	IHME
1,469,660 (1,238,990 - 1,707,930)	1995	Modelled	IHME
1,482,670 (1,254,150 - 1,717,720)	1996	Modelled	IHME
1,488,420 (1,259,960 - 1,724,660)	1997	Modelled	IHME
1,489,580 (1,253,880 - 1,719,980)	1998	Modelled	IHME
1,488,840 (1,246,860 - 1,720,090)	1999	Modelled	IHME
1,488,970 (1,236,610 - 1,724,040)	2000	Modelled	IHME
1,489,980 (1,242,140 - 1,711,960)	2001	Modelled	IHME
1,489,960 (1,246,480 - 1,718,080)	2002	Modelled	IHME
1,488,880 (1,237,050 - 1,727,530)	2003	Modelled	IHME
1,486,670 (1,233,480 - 1,724,580)	2004	Modelled	IHME
1,483,290 (1,224,080 - 1,720,950)	2005	Modelled	IHME
1,478,620 (1,222,420 - 1,711,750)	2006	Modelled	IHME
1,472,480 (1,219,590 - 1,702,500)	2007	Modelled	IHME
1,462,820 (1,215,290 - 1,691,950)	2008	Modelled	IHME
1,451,610 (1,219,600 - 1,690,740)	2009	Modelled	IHME
1,440,780 (1,212,560 - 1,679,710)	2010	Modelled	IHME
1,425,460 (1,206,360 - 1,656,060)	2011	Modelled	IHME
1,405,250 (1,199,620 - 1,616,780)	2012	Modelled	IHME
1,383,830 (1,180,230 - 1,590,080)	2013	Modelled	IHME
1,365,000 (1,165,570 - 1,564,900)	2014	Modelled	IHME
1,352,640 (1,153,180 - 1,543,630)	2015	Modelled	IHME
1,348,790 (1,155,860 - 1,526,670)	2016	Modelled	IHME
1,344,350 (1,150,180 - 1,532,300)	2017	Modelled	IHME
1,330,000 (1,132,390 - 1,498,120)	2018	Modelled	IHME
1,307,320 (1,086,240 - 1,479,900)	2019	Modelled	IHME
4,376,000 (2,427,000 - 4,950,000)	2016	Modelled	Razavi-Shearer et al, 2018

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
12.2 (8.57 - 17.20)	2019	Modelled	IHME
12.3 (8.72 - 17.20)	2018	Modelled	IHME
12 (8.62 - 16.50)	2017	Modelled	IHME
12 (8.64 - 16.30)	2016	Modelled	IHME
12.5 (9 - 16.70)	2015	Modelled	IHME
13.1 (9.64 - 17.20)	2014	Modelled	IHME
13.9 (10.50 - 17.90)	2013	Modelled	IHME
14.6 (11.10 - 18.80)	2012	Modelled	IHME
15.4 (11.80 - 19.70)	2011	Modelled	IHME
15.6 (12.10 - 19.90)	2010	Modelled	IHME
15.7 (12.30 - 20.10)	2009	Modelled	IHME
15.8 (12.30 - 20)	2008	Modelled	IHME
15.9 (12.30 - 20.20)	2007	Modelled	IHME
16 (12.10 - 20.60)	2006	Modelled	IHME
16 (11.90 - 20.60)	2005	Modelled	IHME
16 (11.90 - 20.70)	2004	Modelled	IHME
15.9 (11.60 - 20.50)	2003	Modelled	IHME
15.8 (11.60 - 20.70)	2002	Modelled	IHME
15.7 (11.60 - 20.40)	2001	Modelled	IHME
15.4 (11.30 - 20.20)	2000	Modelled	IHME
15.2 (11 - 20.10)	1999	Modelled	IHME
15.2 (11 - 20.30)	1998	Modelled	IHME
15.2 (11 - 20.30)	1997	Modelled	IHME
15.1 (10.90 - 20.60)	1996	Modelled	IHME
15.1 (10.90 - 20.60)	1995	Modelled	IHME
15.1 (10.80 - 20.80)	1994	Modelled	IHME
15.1 (10.80 - 20.40)	1993	Modelled	IHME
15 (10.60 - 20.70)	1992	Modelled	IHME
15 (10.70 - 20.70)	1991	Modelled	IHME
14.9 (10.60 - 20.40)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
6,644 (4,685 - 9,380)	2019	Modelled	IHME
6,643 (4,728 - 9,313)	2018	Modelled	IHME
6,473 (4,639 - 8,894)	2017	Modelled	IHME
6,386 (4,610 - 8,717)	2016	Modelled	IHME
6,591 (4,760 - 8,848)	2015	Modelled	IHME
6,878 (5,054 - 9,005)	2014	Modelled	IHME
7,232 (5,443 - 9,314)	2013	Modelled	IHME
7,550 (5,741 - 9,700)	2012	Modelled	IHME
7,872 (6,049 - 10,093)	2011	Modelled	IHME
7,906 (6,119 - 10,096)	2010	Modelled	IHME
7,905 (6,166 - 10,074)	2009	Modelled	IHME
7,865 (6,122 - 9,992)	2008	Modelled	IHME
7,892 (6,073 - 10,012)	2007	Modelled	IHME
7,873 (5,928 - 10,084)	2006	Modelled	IHME
7,781 (5,794 - 10,024)	2005	Modelled	IHME
7,721 (5,755 - 9,965)	2004	Modelled	IHME
7,572 (5,563 - 9,797)	2003	Modelled	IHME
7,494 (5,510 - 9,775)	2002	Modelled	IHME
7,357 (5,424 - 9,551)	2001	Modelled	IHME
7,159 (5,253 - 9,379)	2000	Modelled	IHME
6,973 (5,037 - 9,256)	1999	Modelled	IHME
6,901 (4,988 - 9,245)	1998	Modelled	IHME
6,817 (4,933 - 9,154)	1997	Modelled	IHME
6,739 (4,840 - 9,157)	1996	Modelled	IHME
6,659 (4,784 - 9,065)	1995	Modelled	IHME
6,567 (4,697 - 9,016)	1994	Modelled	IHME
6,473 (4,629 - 8,763)	1993	Modelled	IHME
6,367 (4,504 - 8,762)	1992	Modelled	IHME
6,256 (4,482 - 8,643)	1991	Modelled	IHME
6,119 (4,365 - 8,381)	1990	Modelled	IHME
14,284	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
33 (25 - 43)	2019	Modelled	IHME
33 (25 - 43)	2018	Modelled	IHME
33 (25 - 43)	2017	Modelled	IHME
34 (25 - 44)	2016	Modelled	IHME
34 (26 - 44)	2015	Modelled	IHME
35 (27 - 45)	2014	Modelled	IHME
35 (27 - 45)	2013	Modelled	IHME
36 (27 - 46)	2012	Modelled	IHME
36 (28 - 46)	2011	Modelled	IHME
36 (28 - 46)	2010	Modelled	IHME
36 (28 - 46)	2009	Modelled	IHME
36 (28 - 46)	2008	Modelled	IHME
36 (28 - 46)	2007	Modelled	IHME
36 (28 - 46)	2006	Modelled	IHME
36 (28 - 46)	2005	Modelled	IHME
36 (28 - 47)	2004	Modelled	IHME
36 (28 - 47)	2003	Modelled	IHME
36 (28 - 47)	2002	Modelled	IHME
37 (28 - 47)	2001	Modelled	IHME
37 (28 - 47)	2000	Modelled	IHME
37 (28 - 47)	1999	Modelled	IHME
37 (28 - 47)	1998	Modelled	IHME
37 (28 - 47)	1997	Modelled	IHME
37 (28 - 47)	1996	Modelled	IHME
37 (28 - 47)	1995	Modelled	IHME
37 (28 - 47)	1994	Modelled	IHME
37 (28 - 47)	1993	Modelled	IHME
37 (28 - 47)	1992	Modelled	IHME
37 (28 - 47)	1991	Modelled	IHME
37 (28 - 48)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of HepB birth dose

Newborns

Download

Value (%)	Year	Type	Source
7	2018	Survey/reported	WHO/UNICEF
1	2017	Survey/reported	WHO/UNICEF
17	2019	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
91	2018	Survey/reported	WHO/UNICEF
89	2017	Survey/reported	WHO/UNICEF
90	2016	Survey/reported	WHO/UNICEF
89	2015	Survey/reported	WHO/UNICEF
88	2014	Survey/reported	WHO/UNICEF
75	2013	Survey/reported	WHO/UNICEF
58	2012	Survey/reported	WHO/UNICEF
40	2011	Survey/reported	WHO/UNICEF
92	2010	Survey/reported	WHO/UNICEF
91	2009	Survey/reported	WHO/UNICEF
85	2008	Survey/reported	WHO/UNICEF
85	2007	Survey/reported	WHO/UNICEF
75	2006	Survey/reported	WHO/UNICEF
62	2005	Survey/reported	WHO/UNICEF
39	2004	Survey/reported	WHO/UNICEF
8	2003	Survey/reported	WHO/UNICEF
90	2019	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
80 (59 - 120)	2015	Survey/reported	HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.

Technical notes

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

Pregnant women

Source:

HepB birth dose policy

Yes

Source:

Year of birth dose introduction

2016

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

HCV testing policy

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Few (1-10%)

Source: WHO

% of substance use disorder facilities offering hepatitis treatment

None

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
1.82 (1.48 - 2.22)	2019	Modelled	IHME
1.82 (1.49 - 2.23)	2018	Modelled	IHME
1.83 (1.48 - 2.25)	2017	Modelled	IHME
1.83 (1.50 - 2.24)	2016	Modelled	IHME
1.83 (1.49 - 2.25)	2015	Modelled	IHME
1.84 (1.49 - 2.25)	2014	Modelled	IHME
1.84 (1.49 - 2.25)	2013	Modelled	IHME
1.85 (1.49 - 2.29)	2012	Modelled	IHME
1.85 (1.49 - 2.29)	2011	Modelled	IHME
1.86 (1.48 - 2.30)	2010	Modelled	IHME
1.87 (1.50 - 2.32)	2009	Modelled	IHME
1.88 (1.51 - 2.31)	2008	Modelled	IHME
1.89 (1.52 - 2.34)	2007	Modelled	IHME
1.9 (1.53 - 2.36)	2006	Modelled	IHME
1.91 (1.55 - 2.37)	2005	Modelled	IHME
1.93 (1.57 - 2.39)	2004	Modelled	IHME
1.95 (1.58 - 2.41)	2003	Modelled	IHME
1.97 (1.60 - 2.43)	2002	Modelled	IHME
1.99 (1.62 - 2.45)	2001	Modelled	IHME
2.01 (1.63 - 2.46)	2000	Modelled	IHME
2.02 (1.63 - 2.48)	1999	Modelled	IHME
2.03 (1.64 - 2.50)	1998	Modelled	IHME
2.04 (1.64 - 2.52)	1997	Modelled	IHME
2.04 (1.65 - 2.52)	1996	Modelled	IHME
2.05 (1.64 - 2.53)	1995	Modelled	IHME
2.05 (1.65 - 2.53)	1994	Modelled	IHME
2.05 (1.64 - 2.53)	1993	Modelled	IHME
2.06 (1.64 - 2.54)	1992	Modelled	IHME
2.06 (1.64 - 2.53)	1991	Modelled	IHME
2.06 (1.64 - 2.54)	1990	Modelled	IHME

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
0.5 (0.34 - 0.56)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
0.95 (0.34 - 2.03)	2010	Survey/reported	Myo-Khin et al, 2010
1.7 (1 - 2.70)	2014	Survey/reported	Gower et al, 2014
2	2019	Modelled	Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

Showing out of

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
3.4	2019	Modelled	Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

Men who have sex with men (MSM) Living with HIV

Download

Value (%)	Year	Type	Source
3.4 (1.30 - 7.20)	2019	Modelled	Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
29.5 (26.90 - 32.20)	2010	Modelled	Degenhardt L et al, 2017

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
847,674 (672,689 - 1,044,450)	1990	Modelled	IHME
859,523 (685,301 - 1,055,060)	1991	Modelled	IHME
870,622 (693,474 - 1,073,100)	1992	Modelled	IHME
881,027 (705,432 - 1,082,920)	1993	Modelled	IHME
890,780 (714,949 - 1,097,880)	1994	Modelled	IHME
899,913 (721,900 - 1,111,890)	1995	Modelled	IHME
908,204 (732,106 - 1,120,210)	1996	Modelled	IHME
915,452 (738,551 - 1,131,790)	1997	Modelled	IHME
921,769 (743,773 - 1,135,200)	1998	Modelled	IHME
927,226 (749,600 - 1,141,400)	1999	Modelled	IHME
931,857 (754,773 - 1,143,540)	2000	Modelled	IHME
934,128 (758,577 - 1,147,340)	2001	Modelled	IHME
933,482 (754,975 - 1,148,000)	2002	Modelled	IHME
931,474 (754,234 - 1,152,780)	2003	Modelled	IHME
929,713 (754,347 - 1,153,210)	2004	Modelled	IHME
929,890 (751,367 - 1,154,220)	2005	Modelled	IHME
931,782 (748,928 - 1,157,660)	2006	Modelled	IHME
934,084 (751,325 - 1,156,220)	2007	Modelled	IHME
935,637 (751,371 - 1,153,980)	2008	Modelled	IHME
937,846 (753,596 - 1,165,220)	2009	Modelled	IHME
942,136 (751,389 - 1,166,430)	2010	Modelled	IHME
946,917 (761,128 - 1,170,750)	2011	Modelled	IHME
951,911 (770,288 - 1,179,660)	2012	Modelled	IHME
957,242 (775,819 - 1,171,150)	2013	Modelled	IHME
963,031 (780,784 - 1,177,720)	2014	Modelled	IHME
969,368 (788,374 - 1,187,960)	2015	Modelled	IHME
975,977 (799,236 - 1,194,640)	2016	Modelled	IHME
982,671 (797,994 - 1,209,330)	2017	Modelled	IHME
988,594 (808,403 - 1,211,040)	2018	Modelled	IHME
993,498 (808,255 - 1,214,050)	2019	Modelled	IHME

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
74,500 (50,900 - 84,200)	2019	Modelled	Dugan et al., 2021

HCV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
12.5 (8.81 - 17.10)	2019	Modelled	IHME
12.6 (8.94 - 17.30)	2018	Modelled	IHME
12.4 (8.81 - 16.90)	2017	Modelled	IHME
11.9 (8.54 - 16.20)	2016	Modelled	IHME
11.8 (8.47 - 16)	2015	Modelled	IHME
11.5 (8.31 - 15.50)	2014	Modelled	IHME
11.2 (8.03 - 15)	2013	Modelled	IHME
10.8 (7.82 - 14.70)	2012	Modelled	IHME
10.6 (7.61 - 14.40)	2011	Modelled	IHME
10.5 (7.58 - 14.30)	2010	Modelled	IHME
10.5 (7.65 - 14.50)	2009	Modelled	IHME
10.6 (7.67 - 14.70)	2008	Modelled	IHME
10.8 (7.78 - 14.90)	2007	Modelled	IHME
10.9 (7.85 - 15.10)	2006	Modelled	IHME
10.9 (7.79 - 15.10)	2005	Modelled	IHME
10.8 (7.75 - 15)	2004	Modelled	IHME
10.7 (7.62 - 14.80)	2003	Modelled	IHME
10.6 (7.59 - 14.60)	2002	Modelled	IHME
10.5 (7.44 - 14.40)	2001	Modelled	IHME
10.3 (7.23 - 14.20)	2000	Modelled	IHME
10.1 (7.15 - 14.10)	1999	Modelled	IHME
10.1 (7.05 - 14.10)	1998	Modelled	IHME
10.1 (6.97 - 14)	1997	Modelled	IHME
10.1 (6.89 - 14.10)	1996	Modelled	IHME
10.1 (6.87 - 14.10)	1995	Modelled	IHME
10.1 (6.82 - 14.20)	1994	Modelled	IHME
10.1 (6.77 - 14.20)	1993	Modelled	IHME
10 (6.83 - 14.10)	1992	Modelled	IHME
10 (6.83 - 14)	1991	Modelled	IHME
9.97 (6.87 - 14)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
6,829 (4,819 - 9,376)	2019	Modelled	IHME
6,849 (4,849 - 9,398)	2018	Modelled	IHME
6,660 (4,741 - 9,106)	2017	Modelled	IHME
6,370 (4,558 - 8,669)	2016	Modelled	IHME
6,233 (4,481 - 8,488)	2015	Modelled	IHME
6,054 (4,359 - 8,105)	2014	Modelled	IHME
5,802 (4,177 - 7,825)	2013	Modelled	IHME
5,548 (4,029 - 7,556)	2012	Modelled	IHME
5,418 (3,891 - 7,365)	2011	Modelled	IHME
5,300 (3,840 - 7,241)	2010	Modelled	IHME
5,297 (3,841 - 7,285)	2009	Modelled	IHME
5,287 (3,825 - 7,307)	2008	Modelled	IHME
5,326 (3,850 - 7,375)	2007	Modelled	IHME
5,332 (3,852 - 7,415)	2006	Modelled	IHME
5,278 (3,787 - 7,319)	2005	Modelled	IHME
5,227 (3,735 - 7,231)	2004	Modelled	IHME
5,107 (3,638 - 7,050)	2003	Modelled	IHME
5,026 (3,591 - 6,890)	2002	Modelled	IHME
4,910 (3,487 - 6,742)	2001	Modelled	IHME
4,761 (3,356 - 6,592)	2000	Modelled	IHME
4,632 (3,286 - 6,486)	1999	Modelled	IHME
4,585 (3,207 - 6,389)	1998	Modelled	IHME
4,532 (3,134 - 6,295)	1997	Modelled	IHME
4,485 (3,064 - 6,269)	1996	Modelled	IHME
4,435 (3,022 - 6,219)	1995	Modelled	IHME
4,377 (2,964 - 6,167)	1994	Modelled	IHME
4,319 (2,903 - 6,086)	1993	Modelled	IHME
4,252 (2,890 - 5,972)	1992	Modelled	IHME
4,182 (2,848 - 5,853)	1991	Modelled	IHME
4,096 (2,823 - 5,747)	1990	Modelled	IHME
3,792	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
30 (22 - 39)	2019	Modelled	IHME
30 (22 - 38)	2018	Modelled	IHME
30 (22 - 38)	2017	Modelled	IHME
30 (22 - 38)	2016	Modelled	IHME
30 (22 - 38)	2015	Modelled	IHME
30 (22 - 38)	2014	Modelled	IHME
30 (22 - 38)	2013	Modelled	IHME
30 (22 - 38)	2012	Modelled	IHME
30 (22 - 38)	2011	Modelled	IHME
30 (22 - 38)	2010	Modelled	IHME
30 (22 - 38)	2009	Modelled	IHME
30 (22 - 38)	2008	Modelled	IHME
30 (22 - 38)	2007	Modelled	IHME
30 (22 - 38)	2006	Modelled	IHME
30 (22 - 38)	2005	Modelled	IHME
30 (22 - 38)	2004	Modelled	IHME
30 (22 - 38)	2003	Modelled	IHME
30 (22 - 38)	2002	Modelled	IHME
30 (22 - 38)	2001	Modelled	IHME
30 (21 - 38)	2000	Modelled	IHME
30 (21 - 38)	1999	Modelled	IHME
30 (21 - 38)	1998	Modelled	IHME
29 (21 - 38)	1997	Modelled	IHME
29 (21 - 38)	1996	Modelled	IHME
29 (21 - 38)	1995	Modelled	IHME
29 (21 - 38)	1994	Modelled	IHME
29 (21 - 38)	1993	Modelled	IHME
29 (21 - 37)	1992	Modelled	IHME
29 (20 - 38)	1991	Modelled	IHME
29 (20 - 38)	1990	Modelled	IHME

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
80 (59 - 120)	2015	Survey/reported	HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.

Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National

Download

Value	Year	Type	Source
25,167	2016	Survey/reported	CHAI HCV Market Report
20,329	2017	Survey/reported	CHAI HCV Market Report
52,497	2018	Survey/reported	CHAI HCV Market Report
99,305	2019	Survey/reported	CHAI HCV Market Report

Showing out of

Technical notes

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National

Download

Value (US $)	Year	Type	Source
285	2016	Survey/reported	CHAI HCV Market Report
216	2017	Survey/reported	CHAI HCV Market Report
108	2018	Survey/reported	CHAI HCV Market Report
81	2019	Survey/reported	CHAI HCV Market Report